A Randomized, Open-label, Phase 2 Study Of Mdv3100 As A Neoadjuvant Therapy For Patients Undergoing Prostatectomy For Localized Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 26 Dec 2017
At a glance
- Drugs Enzalutamide (Primary) ; Dutasteride; Leuprorelin
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Medivation
- 31 Aug 2018 Biomarkers information updated
- 07 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov records.